Cellectar Biosciences, Inc.
Phospholipid-Flavagline Conjugates and Methods of Using the Same for Targeted Cancer Therapy
Last updated:
Abstract:
Disclosed herein are phospholipid ether (PLE) molecules. Further provided are phospholipid-flavagline conjugates. The phospholipid-flavagline conjugate may include a PLE conjugated to a flavagline via a linker. Further provided herein are methods of treating cancer in a subject and methods of targeting a drug to a tumor or cancer cell in a subject.
Status:
Application
Type:
Utility
Filling date:
10 Apr 2019
Issue date:
3 Jun 2021